Related Experiment Video
Updated: Apr 16, 2026

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
Published on: June 15, 2018
Does proteasome regulate the level of microRNA-1 in cardiomyocytes? Application to anoxia-reoxygenation
Veronika Gurianova1, Dmytro Stroy, Peter Kruzliak
1Bogomoletz Institute of Physiology, National Academy of Science, Kiev, Ukraine.
Abstract:
Proteasome and microRNAs play a critical role in almost all processes in a living organism, including pathology of the heart; however, their interaction is still in question. In the present study, we have found that proteasome inhibitor provoked increase of mature but not immature microRNA-1 in cultured cardiomyocytes, and tested the hypothesis that mature microRNA-1 can be a substrate for endonuclease activity of proteasome. In our in vitro experiments, we have found that proteasome fraction II is able to degrade both mature and primary but not precursor microRNA-1. However, this in vitro effect was not abolished by chemical inhibitor of proteolytic activities of proteasome. These data let us summarize that proteasome has the complex effect on the level of microRNA-1.
Insights
Proteasome inhibition increases mature microRNA-1 in heart cells. The proteasome can degrade microRNA-1, suggesting a complex role in regulating microRNA levels during cardiac pathology.
Area of Science:
- Molecular Biology
- Cardiovascular Biology
- Biochemistry
Background:
- Proteasomes and microRNAs are crucial in cellular processes and heart disease.
- The precise interaction between proteasomes and microRNAs, particularly microRNA-1, remains unclear.
- Understanding this interaction is vital for exploring cardiac pathology mechanisms.
Purpose of the Study:
- To investigate the interaction between proteasomes and microRNA-1 in cardiomyocytes.
- To test the hypothesis that mature microRNA-1 is a substrate for proteasome's endonuclease activity.
- To elucidate the complex role of proteasomes in microRNA-1 regulation.
Main Methods:
- Cultured cardiomyocytes were treated with proteasome inhibitors.
- In vitro experiments assessed the degradation of different microRNA-1 forms by proteasome fraction II.
- Proteolytic activity inhibitors were used to differentiate degradation mechanisms.
Main Results:
- Proteasome inhibition led to increased mature microRNA-1 levels, but not immature forms, in cardiomyocytes.
- Proteasome fraction II demonstrated the ability to degrade both mature and primary microRNA-1 in vitro.
- This degradation activity was independent of the proteasome's chemical proteolytic inhibitors.
Conclusions:
- Proteasomes exhibit a complex regulatory effect on microRNA-1 levels.
- The findings suggest a non-proteolytic mechanism for proteasome-mediated microRNA-1 degradation.
- This study opens new avenues for understanding microRNA regulation in cardiac conditions.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
Regulation of Expression at Multiple Steps
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Regulation of the Unfolded Protein Response

